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Calcium plays an important role in the pathophysiology of pain. A number of studies have investigated the effect of 
L-type calcium channel blockers on the analgesic response of morphine. However, the results are conflicting. In 
the present study, the antinociceptive effect of morphine (2×5 mg) a d nimodipine (1 mg) co-administered intras-
pinally in mice was observed using the tail flick test. It was compared to the analg sic effect of these drugs 
(morphine – 250 mg subcutaneously; nimodipine – 100 mg intraperitoneally) after systemic administration. Ni-
modipine is highly lipophilic and readily crosses the blood brain barrier. Addition of nimodipine to morphine 
potentiated the analgesic response of the latter when administered through the intraspinal route but not when 
administered through systemic route. It may be due to direct inhibitory effect of morphine and nimodipine on 
neurons of superficial laminae of the spinal cord after binding to m-opioid receptors and L-type calcium channels  
respectively. 
[Verma D, Ray S B, Patro I and Wadhwa S 2005 Enhanced analgesic effect of morphine-nimodipine combination after intraspinal admini-
stration as compared to systemic administrtion in mice; J . Biosci. 30 491–497] 
1. Introduction 
Calcium plays an important role in the transmission of 
pain signals in the central nervous system. At the pre-
synaptic nerve terminal, voltage-g t d calcium channels 
(VGCCs) open in response to acti n potentials to allow 
an influx of cal ium ions. The influx is a graded process 
varying in a linear manner with the frequ ncy of action 
potentials. The influx, in turn, leads to release of various 
neurotransmitters that diffuse across the synaptic cleft to 
the postsynaptic membrane and binds to their specific 
receptors. Morphine is the drug of choice for treatment of 
chronic pain (McCarberg and Barkin 2001). It binds to m-
opioid receptor (MOR) on the pre- and postsynaptic 
membranes. However, administration of morphine also 
produces serious side effects like tolerance and depend-
ence, which limits  long-term use. The exact underlying 
reasons for tolerance and dependence are not definitively 
known (Ray and Wadhwa 2001). 
 Binding of morphine to MOR leads to inhibition of 
neurons concerned with transmission of pain. MOR does 
so by blocking VGCCs, opening inwardly rectifying  
potassium channels and inhibiting activity of adenylyl 
cyclase (North 1993). The release of pain producing neu-
rotransmitters like substance P from the presynaptic ter-
minals in the spinal cord is thereby decreased leading to 
relief from pain (Smith e  al 2002). 
 Since their discovery, VGCCs have been the subject of 
intense investigation (Fatt and Katz 1953). Six varieties 
of calcium channels (L-, N-, P-, Q-, R- and T-types) have 
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been demonstarted in neurons (Catterall 2000). Among 
these, the L- and N-types are responsible for neurotrans-
mitter release from sensory neurons of the dorsal column 
of spinal cord (Nowycky et al 1985). A number of studies 
have shown an increase in analgesic response of opioids 
like morphine, when co-administered with L-type cal-
cium channel blockers (CCBs) (Contreras t al 1988; 
Carta et al 1990; Dierssen t al 1990; Omote et al 1993; 
Neugebauer t al 1996; Santillan et al 1998). Contrary to 
this, other reports have found no beneficial effect (Roca 
et al 1996; Hasegawa and Zacny 1997; Diaz and Dickenson
1997; Sluka 1998). Thus, the presnt study was under-
taken to observe the effect of nimodipine, a L-type CCB, 
on morphine-induced analgesia, both after intraspinal 
(intrathecal) and systemic administration in mice. The 
dose of morphine and nimodipine administered intraspi-
nally was 2×5 mg and 1 mg. However, the doses of the 
same drugs were increased by 100 times for systemic 
administration to compensate for increased volume of 
distribution. Nimodipine is highly lipophilic and crosses 
the blood brain barrier in contrast to other CCBs. A poten-
tiation of analgesic effect of morphine would help in 
lowering the dose of morphine. This would bring about a 
corresponding decrease of side effects. This is the first 
report on the interaction between morphine and nimodipi e 
after intraspinal administration. 
2. Methods 
Male mice of Swiss strain (n = 46) weighing between 20–
25 g were procured from the experimental animal facility 
of All India Institute of Medical Sciences. Prior app oval 
of the Institutional Animal Ethics Committee of AIIMS was 
obtained. The animals were housed in well-venti ated 
cages with food and water given ad libitum. Twelve hour 
light and dark cycles were maintained. 
2.1 Drug administration 
The animals were divided into six groups – I to VI (G I-
VI). G I (n = 6) received 2×5 µg of morphine intraspi-
nally, G II (n = 8) received a combination of 2×5 µg of 
morphine and 1µg of nimodipine intraspinally, G III 
(n = 9) received morphine (10 mg/kg) subcutaneously 
while G IV (n = 7) received morphine (10 mg/kg) subcu-
taneously and (10 mg/kg) nimodipine intraperitoneally. 
In G IV, nimodipine was administered 20 min before 
morphine. Only nimodipine (1 µg) was also injected in-
traspinally into a group (G V) of mice (n = 5). A separate 
group (G VI) of mice (n = 6) received nimodipine (10 mg/ 
kg) intraperitoneally. Normal saline was also injected 
intraspinally (n = 5). The amount of morphine injected 
intrathecally was about 1 : 100 of that injected subcuta-
neously. Intrathecal injections were given into the spine 
in the midline (between L5 and L6 vertebrae) in unanaes-
thesized mice using previously standardized technique 
(Hylden and Wilcox 1980). The total volume injected 
intrathecally was 10µl. Subcutaneous injections were 
given in one of the hind limbs. 
2.2 Assessment of sensitivity to noxious thermal stimuli 
The analgesic response was measured by the tail flick 
apparatus (UGO Basile). The animal was placed in a re-
strainer with its tail outside. The tail (distal 1/3rd) was 
exposed to an infrared source of radiation. The animal 
flicks its tail away from the source of heat on feeling 
pain. Baseline latency for the tail flick was recorded at 
the beginning of the experiment and was within 2–4×5 s. 
Analgesic drugs like morphine delay the response time in 
a dose-dependent manner. However, if there was no res-
ponse within 10 s, the animal was removed to prevent 
damage to the tail (cut off time). The maximum permissible
effect (MPE) was calculated from the values of tail flick 
test using the following formula: % MPE = [(observed 
latency-baseline latency)/(cut off time – baseline latency)] × 
100. 
 The tail flick latency was measured after 15 and 30 min 
of morphine and/or nimodipine administration. Subse-
quently it was measured every 30 min till 5 h in G I and 
II and 3×5 h in G III and IV. 
 Statistical evaluation was done using ANOVA with 
post hoc multiple comparisons between groups I–IV only. 
P < 0×05 was considered significant. Results of tail flick 
response from each group were calculated as mean ± 
standard error of mean. 
2.3 Drugs 
Morphine sulphate IP ampoules were purchased from 
Govt. Pharmacy after permission from Narcotic Commis-
sioner. It was diluted in normal saline IP to obtain desired 
concentration. Nimodipine was obtained from Sigma, 
USA. It was dissolved in a solution containing polyethyl ne 
glycol, physiological saline and absolute alcohol in 2 : 2 : 1 
ratio under subdued lighting, as nimodipine is light senstive. 
3. Results 
3.1 General observations 
The analgesic response was evident within 15 min of 
administration of morphine (figure 1). Addition of nimo-
dipine produced 100% response as compared to morphine 
alone, after both intraspinal and systemic administration 
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at 15 min (figure 2). The rate of decrease of analgesi  
was also less, when nimodipine was co-administered 
(G II and IV). Even after 5 h of administra ion, the MPE 
in G II was 37×5% as compared to GI (12×29%). 
3.2 Between-group comparison 
Addition of nimodipine to morphine increased the analgesic 
effect of morphine when given intraspinally (G I nd II; 
figure 1, table 1). The tail flick latency in G II showed a 
significant increase (P < 0×05 at 2, 2×5 and 3 h). Maxi-
mum analgesia was seen as early as 15 min after adminis-
tration. The analgesic response of subcutaneous morphine 
along with intraperitoneal nimodipine showed an increase 
but it was not statis ically significant at any time point 
(G III and IV). Only nimodipine groups (G V and VI) did 
not show any analgesic response. None of the rats showed 
any signs of motor paralysis (intact stepping reflex and 
righting reflex). The saline group showed values close to 
the baseline. 
4. Discussion 
Previous reports indicate that intraspinal administration 
of morphine produces potent analgesia in the postoperative 
period (Cousins and Mather 1984; Domsky and Kwarto-
witz 1992). However, distressing side effects like pruritus, 
urinary incontience, nausea and delayed respiratory de-
pression may complicate its use, particularly in the elderly 
(Slappendel t al 2000; Goodarzi and Narasimhan 2001). 
In order to reduce the incidence of side effects, the 
amount of morphine must be kept to the minimum. One 
way to do this would be to combine it with other drugs so 
as to achieve a potentiation of the analg sic effect of 
morphine. Thus, in the present study, the analgesic effect 
of morphine-nimodipine combination was investigated. 
0
2
4
6
8
10
12
0 15 30 60 90 120* 150* 180* 210 240 270 300
Time (min)
T
a
il 
Fl
ic
k 
T
h
re
sh
o
ld
(s
e
c)
morphine(i.t.)
morphine+nimodipine(i.t.)
morphine(s.c.)
morphine(s.c.)+nimodipine(i.p.)
 
Figure 1. The time course of tail flick latency after intraspinal morphine (G I), intraspinal morphine + nimodipine 
(G II), subcutaneous morphine (G III) and subcutaneous morphine + intraperitoneal nimodipine (G IV) administration. 
Significantly higher threshold (marked with*) was noted in G II as compared all other groups at 2, 2×5 and 3 h 
(P < 0×05). 
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Table 1. The mean, standard error, minimum and maximum values of tail flick latency for all the groups (G I–VII) have been 
shown. The time period for which values of tail flick latency were recorded was one hour for G V–VII.                
Time Groups Number of animals Mean Standard error Minimum values Maximum values               
0:00 G I 
G II 
G III 
G IV 
G V 
G VI 
G VII 
6 
8 
9 
7 
5 
6 
5 
2×4 
2×5 
2×9 
2×9 
2×8 
3×4 
3×1 
0×05 
0×07 
0×26 
0×21 
0×17 
0×27 
0×14 
2×2 
2×2 
1×8 
2×2 
2×3 
2×8 
2×8 
2×5 
2×9 
4×1 
3×8 
3×1 
4×4 
3×3 
0:15 G I 
G II 
G III 
G IV 
G V 
G VI 
G VII 
6 
8 
9 
7 
5 
6 
5 
9×3 
10×0 
9×6 
10×0 
2×6 
2×9 
3×3 
0×62 
0×00 
0×17 
0×00 
0×19 
0×23 
0×26 
6×0 
10×0 
9×0 
10×0 
2×2 
2×0 
2×8 
10×0 
10×0 
10×0 
10×0 
3×1 
3×6 
3×7 
0:30 G I 
G II 
G III 
G IV 
G V 
G VI 
G VII 
6 
8 
9 
7 
5 
6 
5 
8×5 
9×0 
9×5 
10×0 
3×3 
2×8 
3×4 
0×74 
0×45 
0×14 
0×00 
0×27 
0×17 
0×46 
5×9 
6×4 
9×0 
10×0 
2×5 
2×2 
2×6 
10×0 
10×0 
10×0 
10×0 
3×8 
3×5 
4×2 
1:00 G I 
G II 
G III 
G IV 
G V 
G VI 
G VII 
6 
8 
9 
7 
5 
6 
5 
8×0 
10×0 
8×8 
9×3 
2×6 
3×3 
3×7 
0×97 
0×00 
0×56 
0×56 
0×46 
0×26 
0×24 
5×0 
10×0 
5×0 
6×0 
1×6 
2×5 
3×4 
10×0 
10×0 
10×0 
10×0 
3×8 
4×0 
4×2 
1:30 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
7×1 
9×2 
7×6 
8×9 
0×91 
0×53 
0×64 
0×78 
5×3 
5×6 
4×5 
4×6 
10×0 
10×0 
10×0 
10×0 
2:00 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
6×0 
9×0 
4×5 
5×3 
0×90 
0×45 
0×78 
0×49 
3×8 
6×4 
1×8 
3×8 
10×0 
10×0 
10×0 
7×4 
2:30 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
6×4 
8×5 
4×2 
4×7 
0×98 
1×0 
0×58 
0×66 
4×1 
2×5 
2×6 
2×8 
10×0 
10×0 
8×4 
7×8 
3:00 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
5×0 
7×5 
3×3 
4×3 
1×2 
1×0 
0×43 
0×44 
3×0 
3×0 
2×0 
2×0 
10×0 
10×0 
6×0 
6×0 
3:30 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
6×3 
7×8 
2×8 
3×6 
1×3 
1×0 
0×26 
0×53 
2×6 
2×6 
1×3 
2×2 
10×0 
10×0 
3×9 
5×7 
4:00 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
4×6 
6×8 
– 
– 
0×62 
1×0 
– 
– 
3×1 
3×3 
– 
– 
6×8 
10×0 
– 
– 
4:30 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
3×9 
5×5 
– 
– 
0×74 
1×0 
– 
– 
2×7 
2×4 
– 
– 
6×8 
10×0 
– 
– 
5:00 G I 
G II 
G III 
G IV 
6 
8 
9 
7 
3×3 
4×6 
– 
– 
0×11 
0×55 
– 
– 
3×2 
3×0 
– 
– 
3×7 
6×6 
– 
–                
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 The results of the present study indicate that nimodipine 
increases the analgesic effect of morphine. Moreover, the 
intraspinal route appears to be better than systemic ad-
ministration presumably due to the absence of dilution 
within the blood. The dose required is also 1/100th less. 
 Considering the various types of calcium channels and 
their blockers, some degree of uncertainty persists re-
garding the efficacy of various CCBs, when given along 
with morphine (Venegas and Schaible 2000). The reason 
may be that presynaptic terminals from even the same 
axon possess different calcium channels mediating re-
lease of neurot ansmitters, described as a functional patch-
work (Reid et al 2003). Earlier studies have shown a 
superior analgesic effect resulting from combination of 
morphine with L-type CCBs in experimental animals 
when given intrathecally (Omote et al 1993; Dogrul et al 
2001). Even analgesic effect has been noted with only 
CCBs without morphine on intrathecal administration, 
though it was of short duration (15 min) and sometimes 
associated with motor paralysis (Hara et al 1998). In the 
present study, no analgesic effect was observed with only 
nimodipine, probably due to its low dose. Nimodipine 
has been shown to facilitate pain relief in combination 
with morphine in patients suffering from cancer, when 
given orally (Santillan et al 1998). Further, nimodipine 
could prevent the escalation of morphine dosage in a sta-
tistically significant manner without any major side effect 
(dyspepsia being the commonest). 
 To the best of our knowledge, all of the experimental 
studies on the analgesic effect of morphine in combination 
with L-CCBs have recorded pain sensitivity up to 3h. 
However, in the present study, a higher analgesic effect 
of morphine-nimodipine combination was observed even 
at 5 h after intraspinal administration as compared to 
morphine alone (figure 2). Remarkably, more than 1/3rd 
of the peak analgesic effect persisted in G II at 5 h. In a 
clinical scenario, this can make a difference between toler-
able and intolerable pain. It was also persi tently higher 
hroughout the period of observation (15 min to 5 h). 
Thus the combination had an enhanced effect (synergistic 
response) while nimodipine by itself did not have  
an analgesic effect. Further, another dihydropyridine,  
amlodipine had a similar potentiative effect on morphine 
throughout the period of observation for 1 h (Dogrul  
et al 2001). But the dose of amlodipine injected into indi-
vidual rats was 10 mg, which was comparatively much 
higher than i  the present study. Nimodipine is used for 
treatment of hypertension. A previous study did not find 
an  evidence of systemic hypotension after intrathecal 
admi istration of 50mg of nimodipine nor any alteration 
in the blood flow within the spinal cord (Imamura  
and Tator 1998). Presumably, these side effects of  
nimodipine were absent in the present study as the dose 
of nimodipine injected intraspinally was 1 mg. It is possi-
bl  that after systemic administration of morphine-
nimodipine combination, reduced blood flow to the spinal 
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Figure 2. Maximum permissible effect (MPE) observed in G I–IV at different time points as in figure 1. 
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cord and brain may have decreased the analgesic efficacy 
of this combination. 
 Some studies have reported synergi tic effect between 
morphine and N-type CCBs (Omote et al 1996; Wang et al 
2000). Particularly, ziconotide – a synthetic analogue of 
w-conotoxin MVIIA – is being used for treatment of 
neuropathic pain. A related peptide CVID, also known as 
AM336, has been reported to have a larger therapeutic 
window as compared to ziconotide (Smith et al 2002). 
However, neurological side effects are common with N-
type CCBs. 
 A recent report has shown the relative functional im-
portance of different VDCCs in neurons of lamina I of 
the rat spinal cord (Heinke et al 2004). An inhibition of 
postsynaptic current was observed with L-type CCB 
(verapamil) after electrical stimulation of dorsal nerve 
root. However, maximum inhibition was observed with 
N-type CCB (w-conotoxin GVIA). It is possible that in-
traspinal nimodipine could have potentiated the action of 
morphine by a similar mechanism in the present study. 
Neurons of laminae I and II also show higher expression 
of MOR (Ray et al 2005). Thus, morphine could directly 
bind to MOR after intraspinal administration and de-
crease neuronal excitability. Apart from pharmacokinetic 
factors, pharmacodynamic factors also play a role in the 
synergistic interaction between morphine and nimodip-
ine. A recent study has shown that prior administration of 
CCBs (diltiazem, nimodipine and verapamil belonging to 
benzothiazepine, dihy ropyridine and phenylalkylamine 
classes respectively) to morphine significantly increased 
the concentration of the morphine in the serum after sys-
temic administration (Shimizu et al 2004). The increased 
concentration of morphine in the serum produced a statis-
tically significant increase in its analgesic effect. On sys-
temic administration of morphine and nimodipine, we 
also observed a higher analgesic effect though it was not 
statistically significant. These may be explained by the 
different experimental conditions. Interestingly, some of 
the CCBs (diltiazem and verapamil) also increase mor-
phine levels in the brain when co-administered together, 
as compared to morphine alone, after systemic admini-
stration (Shimizu et al 2004). Thus, combinations of 
morphine and CCBs represent exciting clinical entities in 
the near future. 
 In conclusion, the present study highlights the greater 
analgesic effect obtained with combination of morphine 
and nimodipine as compared to morphine alone after intra-
spinal administration. 
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